SeLux Diagnostics has filed a notice of an exempt offering of securities to raise $45,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, SeLux Diagnostics is raising up to $45,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Steve Lufkin played a…
